To analyze if the growth inhibitory effect of exercise serum on LNCaP prostate cancer cells was due to increased apoptosis and/or reduced proliferation, AnnexinV/PI flow FACS (figure S1A) and an EdU incorporation assay was used. The gene discussed is ANXA5; the disease is prostate carcinoma.